marketnews

Join the Fight Against Securities Fraud: The Schall Law Firm Calls for Shareholder Support in Case Against Flux Power Holdings Inc.

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Flux Power Holdings, Inc. LOS ANGELES, CA / ACCESSWIRE / December 17, 2024 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Flux Power Holdings, Inc. (“Flux Power” or “the Company”) (NASDAQ:FLUX) for violations of…

Read More

Psyence Biomed’s Active Phase IIb Clinical Trial: A Promising Update on Recent Progress

Patient Screening Underway for Psyence Biomedical’s Phase IIb Clinical Trial Introduction Patient screening is currently underway for Psyence Biomedical’s Phase IIb clinical trial, with the first patient expected to be randomized into the study in January. This groundbreaking trial is focused on exploring the potential of nature-derived psilocybin, combined with psychotherapy, as a treatment for…

Read More

Meet the New President of Parkland North America: Marcel Teunissen Takes the Lead!

The recent announcement by Parkland Corporation regarding the advancement of executive development and progression within the company has certainly caught the attention of many in the industry. With Brad Monaco being named as the interim Chief Financial Officer, there is a sense of anticipation and excitement surrounding the changes that are set to take place….

Read More

Unleashing the Healing Powers: Duvakitug’s Phase 2b Triumphs in Ulcerative Colitis and Crohn’s Disease!

Duvakitug Positive Phase 2b Results: A Game-Changer in IBD Treatment Breaking News: Sanofi and Teva to revolutionize IBD treatment Exciting Developments in the Field of Immunology Hot off the press! The recent announcement of positive phase 2b results for Duvakitug has sent shockwaves through the medical community, particularly for those suffering from ulcerative colitis (UC)…

Read More

Breaking News: Ideaya’s Groundbreaking Treatment for Metastatic Uveal Melanoma Receives IDMC Recommendation for Dose Advancement in Registration-Enabling Trial

The Independent Data Monitoring Committee (IDMC) has recommended a move-forward dose in Part 2a of a potential registration-enabling trial in 1L HLA-A2-Negative MUM. This recommendation is based on the clinical efficacy and safety observed in over 185 patients enrolled in the trial. The combination of darovasertib and crizotinib has also received U.S. Food and Drug…

Read More

Introducing Ripple’s Stablecoin: RLUSD Goes Live on Major Exchanges!

Ripple’s groundbreaking RLUSD stablecoin launches on Tuesday Ripple Launches RLUSD Stablecoin: The Revolution in Global Payments Begins Ripple is gearing up for the global debut of Ripple USD (RLUSD), an enterprise-grade stablecoin launching on December 17. This new stablecoin is set to transform global payments with instant settlements, defi integration, and unrivaled regulatory compliance. Transforming…

Read More

Bitcoin Soars to New All-Time High Above $107,000: Ethereum, XRP, and Dogecoin Follow Suit as Traders Set Their Sights on Crypto

Bitcoin Hits All-Time High as Trump Considers Strategic Bitcoin Reserve Introduction Bitcoin hit a new all-time high of $107,822 according to Coingecko data on Monday, as bullish hopes are fueled by President-elect Donald Trump reportedly contemplating an executive order to establish a Strategic Bitcoin Reserve. The cryptocurrency market has been experiencing significant gains, with Bitcoin…

Read More